Tabula Rasa HealthCare (TRHC) Tops Q4 EPS by 2c, Offers Guidance

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q4 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $57.3 million versus the consensus estimate of $56.58 million.

GUIDANCE:

Tabula Rasa HealthCare sees Q1 2019 revenue of $55-60 million, versus the consensus of $55.93 million.

Tabula Rasa HealthCare sees FY2019 revenue of $250-260 million, versus the consensus of $251.9 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'